Acne Vulgaris (AV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Acne Vulgaris (AV) Marketed and Pipeline Drugs Report Overview
Acne vulgaris (AV) is currently one of the most common dermatology conditions. It often occurs during adolescence and young adulthood. The disease is a chronic, inflammatory condition of the pilosebaceous glands of the skin. It is initiated during puberty by hormonal changes and further exacerbated by genetic factors.
Key Mechanisms of Action (Marketed) | · Cells & Cell Organelle Inhibitor
· Receptor Agonist · Enzyme Inhibitor · Receptor Antagonist · Protein & Peptide Inhibitor |
Key Molecule Types (Marketed) | · Small Molecule
· Biologic |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Acne Vulgaris (AV) Marketed and Pipeline Drugs Market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for Acne Vulgaris.
The report also provides actionable insights into the clinical and commercial landscapes of Acne Vulgaris (AV)drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.
Key Mechanisms of Action (Pipeline) | · Receptor Agonist
· Enzyme Inhibitor · Genes, Nucleic Acids & Related Components Inhibitor · Receptor Antagonist · Cells & Cell Organelle Disruptor |
Key Molecule Types (Pipeline) | · Small Molecule
· Biologic |
Top Sponsors (Marketed and Pipeline Drugs) | · Galderma SA
· Bausch Health Companies Inc · Taro Pharmaceutical Industries Ltd · Tehran University of Medical Sciences · Hamedan University of Medical Sciences |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Acne Vulgaris (AV) Marketed Drugs Market Segmentation by Mechanisms of Action
The key MoA of the marketed drugs for Acne Vulgaris (AV) includes cells & cell organelle inhibitor, receptor agonist, enzyme inhibitor, receptor antagonist, and protein & peptide inhibitor among others. Most of the marketed drugs followed cells & cell organelle inhibitor MoA in 2023 in the Acne Vulgaris (AV)market.
Acne Vulgaris (AV) Marketed Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Acne Vulgaris (AV) Marketed Drugs
Acne Vulgaris (AV) Marketed Drugs Market Segmentation by Molecule Types
In 2023, the leading molecule type for Acne Vulgaris (AV) marketed drugs was a small molecule, followed by biologic.
Acne Vulgaris (AV) Marketed Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Acne Vulgaris (AV) Marketed Drugs
Acne Vulgaris (AV) Pipeline Drugs Market Segmentation by Mechanisms of Action
The key MoA of the drugs in the Acne Vulgaris (AV) pipeline mainly include receptor agonist, enzyme inhibitor, genes, nucleic acids & related components inhibitor, receptor antagonist, and cells & cell organelle disruptor among others. Most of the pipeline drugs undergoing development for AV followed enzyme inhibit receptor agonist MoA in 2023.
Acne Vulgaris (AV) Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Acne Vulgaris (AV) Pipeline Drugs
Acne Vulgaris (AV) Pipeline Drugs Market Segmentation by Molecule Types
In 2023, the leading molecule type for Acne Vulgaris (AV) pipeline drugs was a small molecule, followed by biologics.
Acne Vulgaris (AV) Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Acne Vulgaris (AV) Pipeline Drugs
Acne Vulgaris (AV) Marketed and Pipeline Drugs Market – Competitive Landscape
A few of the top sponsors in the Acne Vulgaris (AV) marketed and pipeline drugs market are Galderma SA, Bausch Health Companies Inc, Taro Pharmaceutical Industries Ltd, Tehran University of Medical Sciences, and Hamedan University of Medical Sciences among others. Galderma SA sponsored the highest number of trials in 2023.
Acne Vulgaris (AV) Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the Acne Vulgaris (AV) Marketed and Pipeline Drugs Market
Segments Covered in the Report
Acne Vulgaris (AV) Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Cells & Cell Organelle Inhibitor
- Receptor Agonist
- Enzyme Inhibitor
- Receptor Antagonist
- Protein & Peptide Inhibitor
Acne Vulgaris (AV) Marketed Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecule
- Biologic
Acne Vulgaris (AV) Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Enzyme Inhibitor
- Genes, Nucleic Acids & Related Components Inhibitor
- Receptor Antagonist
- Cells & Cell Organelle Disruptor
Acne Vulgaris (AV) Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologic
- Small Molecule
Scope
The key components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Understand the trends shaping and driving the Acne Vulgaris (AV)market to develop business strategies.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Acne Vulgaris (AV)market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which was the leading MoA for Acne Vulgaris (AV) marketed drugs in 2023?
Most of the drugs followed cells & cell organelle inhibitor MoA in 2023 in the Acne Vulgaris (AV) drugs market.
-
Which was the leading molecule type for Acne Vulgaris (AV) marketed drugs in 2023?
In 2023, most of the marketed drugs for AIS were small molecules.
-
Which was the leading MoA for Acne Vulgaris (AV) pipeline drugs in 2023?
Most of the drugs followed receptor agonist MoA in 2023 in the Acne Vulgaris (AV) drugs market.
-
Which was the leading molecule type for Acne Vulgaris (AV) pipeline drugs in 2023?
In 2023, most of the drugs in development for Acne Vulgaris (AV) were small molecules.
-
Which are the top sponsors in the Acne Vulgaris (AV) marketed and pipeline drugs market?
A few of the top sponsors in the Acne Vulgaris (AV) marketed and pipeline drugs market are Galderma SA, Bausch Health Companies Inc, Taro Pharmaceutical Industries Ltd, Tehran University of Medical Sciences, and Hamedan University of Medical Sciences among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.